We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Two white mushrooms.

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

News

4SC Strengthens Patent Protection for Lead Cancer Compound Resminostat

US patent for medical use in cancer and Canadian composition of matter patent granted.

International Standards Group Issues Call for Liquid Handling Experts

Artel to host September meeting of global experts in Maine.

Informatics Tool Helps Scientists Prioritize Protein Modification Research

Researchers have developed a new informatics technology that analyzes existing data repositories of protein modifications and 3D protein structures to help scientists identify and target research on "hotspots" most likely to be important for biological function.

More Accurate and Comprehensive Whole Genome Assembly

Scientists from the Icahn School of Medicine at Mount Sinai have developed a new approach to build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping.

Proteros Appoints Dr. Torsten Hoffmann as Chief Scientific Officer

Dr. Hoffmann will support the further growth of the Company’s Discovery business.

EU Recommends Approval for Alexion's Rare Disease Drugs

Alexion Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending marketing authorization of Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).

Major Step for Implantable Drug-Delivery Device

MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.

Potential New Class of Cancer Drugs

Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.

Creating Bacterial ‘Fight Clubs’ to Discover New Drugs

Creating bacterial “fight clubs” is an effective way to find new drugs from natural sources.

TxCell Announces FDA Acceptance of IND for Ovasave

IND grants TxCell option of extending current phase 2b study from EU to US.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter